Emerald Advisers’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Emerald Advisers's AMGN Position: Q1 2026 in Review
Emerald Advisers sold out of Amgen (AMGN) in Q1 2026, closing a stake of 266 shares — an estimated $87.1K sold.
Emerald Advisers first reported a position in AMGN in Q2 2013 and held it in 16 quarters. The position peaked at $794K in Q3 2024. 3,142 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Emerald Advisers reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
- Emerald Advisers sold 266 Amgen shares in Q1 2026, an estimated $87.1K.
- Emerald Advisers first reported a position in Amgen in Q2 2013 and held it in 16 quarters.
- Emerald Advisers's Amgen position peaked at $794K in Q3 2024.
- 3,142 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Emerald Advisers's 13F filing for Q1 2026, filed 4 May 2026.